Title: | Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with bile duct tumor thrombus(2020) |
Edition: | Original |
Classification: | Experts consensus |
Field: | Diagnosis and Treatment |
Countries and regions: | China |
Guidelines users: | Doctor |
Evidence classification method: | IA evidence derived from Meta-analysis results of multiple randomized controlled studies IB evidence derived from at least one well-designed randomized controlled study IIA evidence derived from at least one well-designed prospective non-randomized controlled study IIB evidence derived from at least one well-designed other type of intervention clinical study III evidence derived from a well-designed non-intervention study, such as descriptive studies, Correlation Studies and other IV evidence from Expert Committee reports or authoritative clinical experience of experts reported |
Development unit: | Chinese Association of Liver Cancer |
Registration time: | 2022-03-06 |
Registration number: | IPGRP-2022CN106 |
Purpose of the guideline: | To standardize the diagnosis and treatment of hepatocellular carcinoma(HCC) with bile duct tumor thrombus |
Latest registration